ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,922.43
-0.81%
US Tech 100
20,695.60
-0.99%
Dow Jones
42,659.76
-0.77%
Brent Oil
74.445
1.11%
Bitcoin
91,972.89
-1.65%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NovoCure Ltd (NVCR)

  7. NovoCure Ltd (NVCR) News

NovoCure Ltd

NovoCure Ltd (NVCR)

NASDAQ
30.45
-0.25
( -0.81% )
Updated: 12:02:54
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

NVCR News

Official News Only

Form 8-K - Current report
Edgar (US Regulatory)
December 02 2024
NVCR (-0.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
November 06 2024
NVCR (-0.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
November 04 2024
NVCR (-0.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
November 04 2024
NVCR (-0.81%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
November 04 2024
NVCR (-0.81%)

NVCR Discussion

View Posts
KIPK KIPK 6 days ago
And you jondickuk, crawling around to save your clients from bad advise you capable of giving..

LOL....
👍️0
whosleftholdindabag whosleftholdindabag 2 weeks ago
$NVCR has reached its 52-week high! Wishing everyone a great weekend! GLTA
👍️0
PonkenPlonken PonkenPlonken 4 weeks ago
Thank you for sharing!
They seem to believe this makes it to market in CRC is my read.
👍️0
jondoeuk jondoeuk 4 weeks ago
A phase 2 trial, PANOVA-4, will test TTFields combined with a triplet regimen of gemcitabine, nab-paclitaxel and atezolizumab as a first-line treatment for metastatic pancreatic ductal adenocarcinoma. It has completed enrolment and the company said it expects to have data in 2026.

The primary endpoint is disease control rate (DCR). Secondary endpoints include, overall survival (OS), progression-free survival (PFS), 1-year OS rate, objective response rate (ORR), PFS at 6 months, duration of response, and safety.
👍️0
whosleftholdindabag whosleftholdindabag 4 weeks ago
$NVCR what a great way to kick off December, don't you know? Where are all the bloody naysayers today? We're raising a lot of money for charity! GLTA
👍️0
jondoeuk jondoeuk 4 weeks ago
Novocure plans to file for regulatory approval in the U.S., EU, Japan and other key markets; Zai Lab plans to file for regulatory approval in China https://www.businesswire.com/news/home/20241202363277/en/Zai-Lab-and-Novocure-Announce-Positive-Topline-Results-from-Phase-3-PANOVA-3-Clinical-Trial-of-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer
👍️ 1
tw0122 tw0122 4 weeks ago
Looking good $30 +
50% 
12:09 PM EST, 12/02/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.)NovoCure's (NVCR) shares rose more than 41% in recent Monday trading after the company and Zai Lab (ZLAB) said that their phase 3 trial evaluating TTFields along with gemcitabine and nab-paclitaxel as a treatment for unresectable, locally advanced pancreatic adenocarcinoma achieved its primary endpoint, demonstrating a "statistically significant" improvement in median overall survival.NovoCure (NVCR) plans regulatory filings in the US, EU, Japan, and other major markets, while Zai Lab plans to file for regulatory approval in China, the companies said.
👍️0
PonkenPlonken PonkenPlonken 4 weeks ago
would love to see new session high
data is hot --- Can become SOC
👍️0
whosleftholdindabag whosleftholdindabag 1 month ago
$NVCR back above $20! GLTA
👍️0
Invest-in-America Invest-in-America 2 months ago
NVCR: One has to be patently BRAIN DEAD to attribute any significance whatsoever to the 1890's-like ELECTRICAL, cure-all, gadgets that this obvious SCAM company promotes!!!
👍️ 1
jondoeuk jondoeuk 2 months ago
FDA Approves Novocure’s Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer https://www.businesswire.com/news/home/20241015381082/en
👍️ 1 💥 1
whosleftholdindabag whosleftholdindabag 2 months ago
Lovely action AH $NVCR! I can't wait for the opening bell, wishing everyone a great evening! GLTA
👍️0
whosleftholdindabag whosleftholdindabag 2 months ago
$NVCR great way to end the trading day! GLTA
👍️0
whosleftholdindabag whosleftholdindabag 3 months ago
I own both $NVCR and $NWBO, all proceeds will go to charity. GLTA
👍️0
KIPK KIPK 3 months ago
Glad to see you are in the right stock, NWBO, now!!
👍️0
TiltMyBrain TiltMyBrain 4 months ago
Who is the bag holder now???

Going to single digits
👍️ 1
whosleftholdindabag whosleftholdindabag 5 months ago
Come fly with me, let's fly let's fly away! Ol blue eyes, what a beautiful voice! Great start $NVCR! GLTA
🚽 2
whosleftholdindabag whosleftholdindabag 5 months ago
Back above $20 $NVCR! GLTA
🚽 1
whosleftholdindabag whosleftholdindabag 7 months ago
Another week, another beautiful day for $NVCR shareholders! GLTA
🐀 1
whosleftholdindabag whosleftholdindabag 7 months ago
Another beautiful start of the week for $NVCR! GLTA
😂 1
KIPK KIPK 7 months ago
LOL - Go from over $200 to $20.
Wondering why this charity worker is NWBO hater.
Wondering why a self proclaimed good spirit tries so hard to destroy a great cancer therapy company. NWBO, hat is not NVCR??
A true charity worker expected to be compassionate, caring, and greatful of all possible potentials...

BUT not this guy??

You judge!!!

KARMA!!
👍️ 3 💯 2
whosleftholdindabag whosleftholdindabag 7 months ago
GO $NVCR GO! We're making A LOT of $$$$$ for charities don't you know? GLTA
⚠️ 1
whosleftholdindabag whosleftholdindabag 8 months ago
Beautiful day $NVCR! GLTA
👎️ 2 🤣 2
whosleftholdindabag whosleftholdindabag 8 months ago
It's been another great week for $NVCR! Have a wonderful weekend everyone! GLTA
👎️ 2 🚫 1 🤣 1
TiltMyBrain TiltMyBrain 8 months ago
Insiders to sell shares in 30 days
👍️ 2 💥 2
KIPK KIPK 8 months ago
LOL 🤣🤣🤣
👍️ 2 💯 1
dstock07734 dstock07734 8 months ago
Or you can simply wait.
👍️ 1 🤣 2
whosleftholdindabag whosleftholdindabag 8 months ago
Well that's fantastic mate! Perhaps I'll have my lawyer contact her, have a great weekend! GLTA
🤣 1 ⚠️ 1
dstock07734 dstock07734 8 months ago
By now, you should be smart enough to know that Laura Posner or Elliott Leary would be able to get IP address of each poster on NWBO board.
👍️ 4
dstock07734 dstock07734 8 months ago
libel? Which part is libel? Nemesis18's post style is very similar to yours, would you agree?
👍️ 3 🤣 2
whosleftholdindabag whosleftholdindabag 8 months ago
No, do you? GLTA
⚠️ 1
whosleftholdindabag whosleftholdindabag 8 months ago
I'd be careful you're getting a wee bit close to libel don't you know? GLTA
🚫 1 🤣 1
whosleftholdindabag whosleftholdindabag 8 months ago
Great way to end the week! Finish strong $NVCR! Have a great weekend everyone! GLTA
🚫 1 🤣 1
whosleftholdindabag whosleftholdindabag 8 months ago
You're posting on the wrong board mate, $NWBO is the one dealing with toxic financers go over there and post your rubbish! GLTA

Streeterville Capital, LLC is a Chicago-based company owned by John M. Fife, who has been described as a "toxic lender" for many years. Toxic financing is a type of financing that companies use when they are in poor condition and can't get financing in any other way. It can come in the form of convertible debt or convertible preferred stock and often gives the debtholder an unlimited number of common shares when they convert their debt or preferred shares to common stock.
👍️ 1
TiltMyBrain TiltMyBrain 8 months ago
Toxic financing for a company who’s price is down 90% in last 3 years
👍️ 2 💥 2
TiltMyBrain TiltMyBrain 8 months ago
Today is the pump. Tomorrow is the insider dump
👍️ 2 💥 2
KIPK KIPK 8 months ago
What a great day right Nemeses 18?
How is dat charity holding da bag???
👍️ 2 😂 2 🤣 1
KIPK KIPK 8 months ago
Gone with the wind on wings of fake therapy IMO
👍️ 2 💯 1
KIPK KIPK 9 months ago
20? including a PRE-CLINICAL???? lol
And all that unfocused activity signal the total desperation to keep the SP up IMO...

Reminds me of INO, which also kept throwing stuff at every possible thing, hoping one would stick.... But NO... INO SP at one time was over $2000 & now is around $11 after a recent RS
👍️ 1
axelvento axelvento 9 months ago
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

https://www.biospace.com/article/releases/novocure-announces-20-presentations-on-tumor-treating-fields-highlighting-preclinical-effects-in-pancreatic-cancer-and-immune-effects-at-american-association-for-cancer-research-aacr-annual-meeting-2024/
👎️ 2 🤣 1
TiltMyBrain TiltMyBrain 9 months ago
https://x.com/peter_brit/status/1775041789889491437?s=46&t=1nHn7IXseo2gJ7ymtRCgUA

This ship is sinking fast!
👍️ 3 👏 3
TiltMyBrain TiltMyBrain 9 months ago
insider selling in 3...2...1...
👍️ 3 💯 3 😂 1 🤣 1
TiltMyBrain TiltMyBrain 9 months ago
"Preliminary analyses of key secondary endpoints (time to neurocognitive failure, overall survival, and radiological response rate) did not demonstrate statistical significance."

pump and dump in progress
👍️ 2 💯 2 🤣 1
whosleftholdindabag whosleftholdindabag 9 months ago
Loving the early action on $NVCR. Wishing everybody a great day! GLTA
🐀 1 🗑️ 1 🤣 2
KIPK KIPK 9 months ago
LOL - "In time to Intracranial Progression" ??? SMH
👍️ 1
Awl416 Awl416 9 months ago
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
👍️ 2 💯 1
KIPK KIPK 9 months ago
The Vanishing tin can on the wind of ineffectiveness!!
Have a kick at it MATE - LOL !!
👍️ 1
KIPK KIPK 9 months ago
You just made a positive post for NWBO without knowing it MATE. Think JAMA.....

And that's So sad as You must be in total loss for words to be citing here a post by a Paid NWBO Basher, InquiriNg. At least you should have given the credit as she, just like you, has been lost for words as well MATE!! . LOL Mate!!

You Birt got nothing & the tin hat is made for a tin man... just like you & the charity investor scamwannabe!!
LOL
👍️ 4 🤣 2
jondoeuk jondoeuk 9 months ago
NWBO's DCVax-L is an expensive placebo. The same is true for DCVax-Direct.
👍️ 1 💯 1 🗑️ 3 ❌️ 2
KIPK KIPK 9 months ago
Congrats whosbagholding. You keep expanding your reach into Charity Work. LOL - SMH...

Below is a response to one of your good will intention (LOL) on NWBO MB>>>>
Re: AAPL31415926 post# 679357

Monday, March 18, 2024 8:40:02 AM

Post#
679360
of 679363
Amazing that whosbagholding gave me a clown emoji on this comment. It shows how absolutely evil these people are. Hopefully he/she/it/they don't have to face their spouse or one of their children being diagnosed with a fatal disease that they work hard to try and destroy a cure for. Then again there's always karma.
👍️0

Your Recent History

NASDAQ
NVCR
NovoCure
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads